Dr Helen McBreen, is Investment Director at Atlantic Bridge Capital a Global Technology Fund with over $500 million of assets under management across five Funds, investing in technology companies in Europe, the US and China.
Helen manages Atlantic Bridge’s €60m University Bridge Fund which is focused on investing in early stage companies with global potential that are built from world class research generated at Irish universities. The Fund provides capital and expertise for scaling companies into international markets. Under Helen’s leadership this Fund has so far led seed investments into several high potential companies: Sprite Robotics (robotics), Kastus Technologies (anti-microbial materials), Ambisense (IOT), Siren Solutions (big data), Proverum (medtech) and Coras.io (fintech).
Prior to joining Atlantic Bridge Capital, Helen was an Investor at NDRC, one of Ireland’s leading accelerators and early stage tech investor. Helen played a key role in the allocation of €45m capital into over 100 new technology ventures with a particular focus on ventures in energy, health and ICT.
Helen is Board Member and Advisor to several organisations include: eHealth Ireland, Knowledge Transfter Ireland, HealthXL Platform, UCD MSc Innovation, Entrepreneurship and Design, Enterprise Ireland Business Advisor in International Selling, UCD VentureLaunch and is a mentor to a number of tech start-ups.
Earlier in her career Helen held the position of Sales Director at Celtrak Ltd (acquired by Thermo King, 2015). She understands sales intimately, and in her role as Business Advisor to Enterprise Ireland client companies she works with growth stage companies to help them overcome expansion challenges in international markets.
Having earned a First Class honours electronic engineering degree from UCD and a PhD from The University of Edinburgh, Helen is a technologist and is particularly interested in technologies based on AI, robotics, big data & data science, bioinfomatics, medtech, neuroscience, connected health and nanotech.
In 2014, Helen successfully initiated and implemented ‘FutureHealth’ in partnership with EY, ICON, UCD and Enterprise Ireland, with the objective of finding ten new healthtech startups from across Ireland. FutureHealth was recognised as Ireland’s first early stage healthtech accelerator.
Finally, Helen received peer recognition when she was listed as one of the Top 100 Women in STEM in Ireland.